GTx, Inc. (NASDAQ:GTXI)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Recs

0
Player Avatar sogreek (< 20) Submitted: 7/24/2007 4:38:26 PM : Outperform Start Price: $14.96 GTXI Score: -70.95

has taken a beatin lately...but I am still in love with the pipeline.

Featured Broker Partners


Advertisement